Page last updated: 2024-08-24

2-oxindole and Hepatocellular Carcinoma

2-oxindole has been researched along with Hepatocellular Carcinoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Chua, BT; Go, ML; Ho, HK; Hui, KM; Lim, KS; Ong, HT; Teo, V; Ullrich, A; Wong, W; Zhang, W	1

Other Studies

1 other study(ies) available for 2-oxindole and Hepatocellular Carcinoma

Article	Year
Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma. Molecular oncology, 2014, Volume: 8, Issue:7 Topics: Animals; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Humans; Indoles; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxindoles; Protein Kinase Inhibitors; Protein-Tyrosine Kinases	2014

Article

Year

Benzylidene-indolinones are effective as multi-targeted kinase inhibitor therapeutics against hepatocellular carcinoma.

Molecular oncology, 2014, Volume: 8, Issue:7

Topics: Animals; Antineoplastic Agents; Apoptosis; Benzylidene Compounds; Carcinoma, Hepatocellular; Cell Line, Tumor; Female; Humans; Indoles; Liver; Liver Neoplasms; Mice; Mice, Inbred BALB C; Oxindoles; Protein Kinase Inhibitors; Protein-Tyrosine Kinases

2014